Table A4. Government Performance Results Act (GPRA) Sexually Transmitted Diseases Goals and Measures

GPRA Goals	Baseline	Actual Performance		Long-Term Goal
	2002	2005	2006	2010
Goal 1: Reduction in PID (as measured by initial visits to physicians in women 15-44 years of age)	197,000	176,000	106,000	168,000
a. Prevalence of Chlamydia in high-risk women 25 years	10.1%*	9.2%*	13.1%*	8.6%*
b. Prevalence of Chlamydia in women 25 years in family planning clinics	5.6%*	6.3%*	6.7%*	4.9%*
c. Incidence of Gonorrhea/100,000 population in women 15-44 years of age	279	275	290	237
Goal 2: Elimination of Syphilis (as measured by incidence of P&S Syphilis/100,000 population)	2.4	2.9	3.3	2.2
a. Incidence of P&S Syphilis/100,000 population - men	3.8	5.1	5.7	4.2
b. Incidence of P&S Syphilis/100,000 population - women	1.1	0.9	1.0	0.38
c. Incidence of Congenital Syphilis/100,000 live births	10.2	8.2	8.5	3.9
d. Black:white rate ratio of P&S Syphilis	8:1	5.4:1	5.9:1	3:1

GPRA Goals	Data Source
1	National Disease and Therapeutic Index (IMS Health).
1-a	National Job Training Program.
1-b	Regional Infertility Prevention Projects (IPP).
1-c	STD Surveillance System (STDSS), CDC, NCHHSTP.
2	STD Surveillance System (STDSS), CDC, NCHHSTP.
2-a	STD Surveillance System (STDSS), CDC, NCHHSTP.
2-b	STD Surveillance System (STDSS), CDC, NCHHSTP.
2-c	STD Surveillance System (STDSS), CDC, NCHHSTP.
2-d	STD Surveillance System (STDSS), CDC, NCHHSTP.

*Median state-specific chlamydia prevalence among women was not adjusted for changes in laboratory test method and associated increases in test sensitivity.